Get started
Author

Chantal Guilhaume

Observed names: C Guilhaume, C. Guilhaume, C. Guilhaume–Goulant, CHANTAL GUILHAUME, Chantal Guilhaume-Goulant
OpenAlex ID: A5037618306
Cost Effectiveness of Memantine in Alzheimer???s Disease: An Analysis Based on a Probabilistic Markov Model from a UK Perspective
2004 · Roy W Jones, Paul McCrone, et al. · Drugs & Aging · 64
A dependency model for patients with Alzheimer's disease: its validation and relationship to the costs of care – the LASER-AD Study
2004 · G. Livingston, C. Katona, et al. · Current Medical Research and Opinion · 52
Cost-Effectiveness of Memantine Compared with Standard Care in Moderate-to-Severe Alzheimer Disease in Canada
2007 · Micheline Gagnon, Benoît Rive, et al. · The Canadian Journal of Psychiatry · 38
PDF
New assessment of dependency in demented patients: Impact on the quality of life in informal caregivers
2007 · SANDRINE ANDRIEU, BENOÎT RIVE, et al. · Psychiatry and Clinical Neurosciences · 38
PDF
Regulatory and health technology assessment advice on postlicensing and postlaunch evidence generation is a foundation for lifecycle data collection for medicines
2020 · Jane Moseley, Spiros Vamvakas, et al. · British Journal of Clinical Pharmacology · 36
PDF
Cost-effectiveness of memantine in community-based Alzheimer’s disease patients: an adaptation in Spain
2006 · Fernando Antonanzas, Benoit Rive, et al. · The European Journal of Health Economics · 32
Cost effectiveness of memantine in Alzheimer's disease in the UK
2010 · B. Rive, M. Grishchenko, et al. · Journal of Medical Economics · 28
PDF
Development and Pilot Test of the Registry Evaluation and Quality Standards Tool: An Information Technology–Based Tool to Support and Review Registries
2022 · Alexander Allen, Hannah Patrick, et al. · Value in Health · 24
PDF
A tool to assess the registries quality: The Registry Evaluation and Quality Standards Tool (REQueST)
2021 · C Guilhaume · European Journal of Public Health · 13
PDF
Characteristics and health status change over 6 months in people with moderately severe to severe Alzheimer's disease in the U.K.
2006 · Gill Livingston, Cornelius Katona, et al. · International Psychogeriatrics · 13
Modeling stroke management: a qualitative review of cost-effectiveness analyses
2010 · Chantal Guilhaume, Delphine Saragoussi, et al. · The European Journal of Health Economics · 12
Cost-effectiveness analysis of memantine for moderate-to-severe Alzheimer's disease in the Netherlands
2011 · Rive, Bart Hoogveldt, et al. · Neuropsychiatric Disease and Treatment · 10
PDF
Postlaunch evidence generation practices among health technology assessment bodies in Europe
2022 · Janet Puñal-Riobóo, Leonor Varela-Lema, et al. · International Journal of Technology Assessment in Health Care · 6
A chart review of management of ischemic stroke patients in Germany
2015 · Patrice Verpillat, Chantal Guilhaume-Goulant, et al. · Journal of Market Access & Health Policy · 5
PDF
Ischemic stroke management in West Scotland: a chart review
2015 · Patrice Verpillat, Chantal Guilhaume-Goulant, et al. · Journal of Market Access & Health Policy · 4
PDF
Pnm10 Cost Effectiveness of Memantine in the Treatment of Moderately Severe and Severe Alzheimer's Disease in Spain
2003 · F Antonanzas, J Badenas, et al. · Value in Health · 4
Php318 - Experience With Early Dialogues (ed) in Eunethta Ja3
2018 · M. Galbraith, C. Guilhaume, et al. · Value in Health · 1
Geographical Disparities in Multiple Myeloma Survival in Three French Regions
2016 · Morgane Mounier, Nicolas Despiégel, et al. · Blood · 1
5-Year Overall Survival and Progression-Free Survival in Multiple Myeloma by Line of Treatment from the French Hematologic Malignancy Registry
2016 · M Mounier, S Gauthier, et al. · Value in Health · 1
PDF
Pdb4 the Health-economic Implications of the “irbesartan in Diabetic Nephropathy Trial” (idnt) in France and Belgium
2002 · AJ Palmer, L Annemans, et al. · Value in Health · 1
PDF
OP12 Post-Launch Evidence Generation Among Health Technology Assessment Bodies In Europe
2022 · Leonor Varela Lema, Janet Puñal-Riobóo, et al. · International Journal of Technology Assessment in Health Care
PDF
OP152 Level Of Agreement In EUnetHTA Joint Action 3 Early Dialogues
2018 · Judith Fernandez, Chantal Guilhaume, et al. · International Journal of Technology Assessment in Health Care
PDF
Quality of Life of Patients Treated for Multiple Myeloma (MM) in France in a Real-World Setting
2016 · N Despiegel, C Touboul, et al. · Value in Health
Pcv25 Management of Acute Ischemic Stroke and Its Long Term Evolution in the United States and Canada
2011 · A. Rouleau, V. Gobaux, et al. · Value in Health
PDF
Pmh35 Cost-effectiveness of Memantine in the Treatment of Moderate and Severe Alzheimer's Disease Patients With Agitation, Aggression and Psychosis—the Uk Example
2010 · B Rive, M Grishchenko, et al. · Value in Health
PDF
Works count: 37
Citation count: 383
H-index: 11
I10-index: 12
Year
Topic
Type